RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Dynavax Technologies Stock

Dynavax Technologies ROCE 2024

Dynavax Technologies ROCE

-0.05

Ticker

DVAX

ISIN

US2681582019

WKN

A12EV9

In 2024, Dynavax Technologies's return on capital employed (ROCE) was -0.05, a -111.17% increase from the 0.49 ROCE in the previous year.

Dynavax Technologies Aktienanalyse

What does Dynavax Technologies do?

Dynavax Technologies Corp is a US-based biotechnology company that specializes in developing innovative therapies and vaccines to combat infectious diseases and cancer. The company was founded in 1996 and is headquartered in Emeryville, California. Dynavax's roots can be traced back to the research work of Dr. Lawrence Steinman, a renowned immunologist at Stanford University. The company initially focused on researching autoimmune diseases such as multiple sclerosis and arthritis. In 2001, Dynavax received approval from the US Food and Drug Administration (FDA) for their first developed product called HEPLISAV, a hepatitis B vaccine. The company's business model is based on researching and developing therapies and vaccines based on immunology and genetics. Dynavax conducts intensive research in its laboratories to develop new treatment approaches and vaccines. The company collaborates closely with universities, government institutions, and other biotechnology companies to test and verify the effectiveness and safety of its products. Dynavax is divided into several divisions to oversee its product development and distribution activities. These divisions include vaccines, oncology, and autoimmune diseases. Dynavax has introduced several products to the market in recent years, including HEPLISAV, SD-101, AZD1419, and DYVAX FQ. The company continues to focus on researching and developing new therapies and vaccines. Dynavax Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Dynavax Technologies's Return on Capital Employed (ROCE)

Dynavax Technologies's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Dynavax Technologies's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Dynavax Technologies's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Dynavax Technologies’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Dynavax Technologies stock

What is the ROCE (Return on Capital Employed) of Dynavax Technologies this year?

The ROCE of Dynavax Technologies is -0.05 undefined this year.

How has the ROCE (Return on Capital Employed) of Dynavax Technologies developed compared to the previous year?

The ROCE of Dynavax Technologies has increased by -111.17% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Dynavax Technologies?

A high Return on Capital Employed (ROCE) indicates that Dynavax Technologies has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Dynavax Technologies?

A low ROCE (Return on Capital Employed) can indicate that Dynavax Technologies has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Dynavax Technologies impact the company?

An increase in the ROCE of Dynavax Technologies can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Dynavax Technologies affect the company?

A decrease in ROCE of Dynavax Technologies can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Dynavax Technologies?

Some factors that can affect Dynavax Technologies's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Dynavax Technologies so important for investors?

The ROCE of Dynavax Technologies is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Dynavax Technologies take to improve the ROCE?

To improve the ROCE, Dynavax Technologies can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Dynavax Technologies pay?

Over the past 12 months, Dynavax Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Dynavax Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Dynavax Technologies?

The current dividend yield of Dynavax Technologies is .

When does Dynavax Technologies pay dividends?

Dynavax Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Dynavax Technologies?

Dynavax Technologies paid dividends every year for the past 0 years.

What is the dividend of Dynavax Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Dynavax Technologies located?

Dynavax Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Dynavax Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Dynavax Technologies from 12/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/2/2024.

When did Dynavax Technologies pay the last dividend?

The last dividend was paid out on 12/2/2024.

What was the dividend of Dynavax Technologies in the year 2023?

In the year 2023, Dynavax Technologies distributed 0 USD as dividends.

In which currency does Dynavax Technologies pay out the dividend?

The dividends of Dynavax Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Dynavax Technologies

Our stock analysis for Dynavax Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dynavax Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.